Researchers find clue to rare genetic disorder
Leber hereditary optic neuropathy (LHON) is an inherited form of vision loss that causes people to have trouble with their colour vision and difficulty seeing in the centre of their visual field. Due to the founder effect from the filles du roi, there is a disproportionate preponderance of a particular LHON mutation among the French-Canadian population.
Study could lead to development of personalized biomarkers and treatment
Individuals with autism spectrum disorder (ASD) are often lumped into a single catch-all group, despite significant differences in symptom profile and severity. Further muddying the waters when trying to understand and treat ASD, many previous studies show significant variability in findings.
New study of brain neurotransmitter receptor has implications for drug discovery
Surprisingly complex movements in an important neurotransmitter receptor may help explain the brain’s unpredictable response to drugs, according to a new study. New research from an international team, published this week in the journal Neuron, has revealed that the resting state of signaling proteins are much more dynamic than previously thought.
McGill University’s Faculty of Medicine unveiled a new strategic research plan (SRP) for the Faculty in 2014, which was subsequently updated in 2017 as part of the strategic planning exercise known as Project Renaissance. Dr. Shari Baum, who recently assumed the role of Vice-Dean, Life Sciences, played an important role in the development of the most recent version of the plan. Dr.
Growing up in the Croatian capital city of Zagreb, Dr. Ante L. Padjen, Associate Professor (post- retirement) at McGill University, found inspiration in the orchestra of the Croatian Institute of Music (CIM). Founded in 1827, the CIM has mostly been an ensemble comprised of physicians, lawyers, engineers and students, conducted by a professor from the Zagreb Music Academy. Following an opportunity to play briefly with CIM himself, Dr.
Deanna MacNeil from the Autexier lab establishes how an imbalance favoring telomerase RNA degradation over correct maturation is causative for the premature aging telomere biology disorder dyskeratosis congenita.
The telomerase holoenzyme responsible for maintaining telomeres in vertebrates requires many components in vivo, including dyskerin. Dyskerin binds and regulates the accumulation of the human telomerase RNA, hTR, as well as other non-coding RNAs that share the conserved H/ACA box motif.
By Gillian Woodford
An innovative interdisciplinary PhD program will bridge the gap between the quantitative and biological domains to improve life sciences research.
Study sheds light on longstanding debate
By Josh Kaiser
For about 20% to 30% of breast cancer patients, their primary tumour will spread to other organs such as the bones, lungs, liver, or brain. Remarkably, this metastasis to other organs accounts for 90% of deaths during breast cancer treatment. Unfortunately, many of the specific cellular processes regulating breast cancer metastasis are poorly understood and there are currently no targeted treatments.
By Matthew Brett
McGill University is now home to a new Institute of Health Sciences Education thanks to a motion approved by its Board of Governors in February.
The Institute, which replaces the existing Centre for Medical Education, is now an academic hiring and teaching unit that can provide graduate programs in health sciences education.
Students from the McGill University Faculty of Medicine’s School of Communication Sciences and Disorders (SCSD) have once again been busy organizing a series of events for spring 2019. Working under the guidance of Dr.
March 24th is World TB Day. Tuberculosis (TB) is an ancient disease that killed humans as far back as 600 BC. Sadly, even in 2019, it is the leading infectious killer of humanity.
Large international study will help select and categorize patients for better clinical trials
A large multi-centre study of more than 1,200 patients provides important predictors of Parkinson’s disease progression, which will allow better candidate selection for clinical trials and more effective therapy development.
A native Montrealer, Dr. Gabrielle Cassir completed her medical school and residency training at Université de Montreal. During her time as a medical student, she was also able to experience the American health care system, spending two months at Jackson Memorial Hospital in Miami.